International trends in sales of inhaled fenoterol, all inhaled beta-agonists, and asthma mortality, 1970-1992. (Q53361259)

13 May 2018

title

International trends in sales of inhaled fenoterol, all inhaled beta-agonists, and asthma mortality, 1970-1992. (English)

1 reference

13 May 2018

0 references

Lanes SF

1

1 reference

13 May 2018

Birmann B

series ordinal

2

1 reference

13 May 2018

Raiford D

series ordinal

3

1 reference

13 May 2018

Walker AM

series ordinal

4

1 reference

13 May 2018

publication date

1 March 1997

1 reference

13 May 2018

Journal of Clinical Epidemiology

published in

1 reference

13 May 2018

volume

50

1 reference

13 May 2018

issue

3

1 reference

13 May 2018

page(s)

321-328

1 reference

13 May 2018

Rise and fall of asthma mortality in England and Wales in relation to use of pressurised aerosols

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900375-7

7 January 2021

Mortality from asthma: a new epidemic in New Zealand

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900375-7

7 January 2021

Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900375-7

7 January 2021

The use of beta-agonists and the risk of death and near death from asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900375-7

7 January 2021

Risk of severe life threatening asthma and beta agonist type: an example of confounding by severity

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900375-7

7 January 2021

End of the New Zealand asthma mortality epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900375-7

7 January 2021

Beta 2-agonists and death from asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900375-7

7 January 2021

Accuracy of certification of deaths due to asthma. A national study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900375-7

7 January 2021

End of New Zealand asthma epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900375-7

7 January 2021

Acute laryngeal obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900375-7

7 January 2021

Major reduction in asthma morbidity and continued reduction in asthma mortality in New Zealand: what lessons have been learned?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900375-7

7 January 2021

Regular inhaled beta-agonist treatment in bronchial asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900375-7

7 January 2021

Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900375-7

7 January 2021

Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900375-7

7 January 2021

Regular inhaled salbutamol and airway responsiveness to allergen

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900375-7

7 January 2021

10.1016/S0895-4356(96)00375-7

Identifiers

DOI

1 reference

13 May 2018

release_fkzq52ys25fjzlmh4jvcla57j4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fkzq52ys25fjzlmh4jvcla57j4

24 November 2022

mapped directly with Wikidata item

1 reference

13 May 2018